WallStreetZenWallStreetZen

NASDAQ: VNDA
Vanda Pharmaceuticals Inc Stock Ownership - Who owns Vanda Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vanda Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gunther BirznieksSVP Business Development2026-03-0242,431$8.27
$350.73kSell
Kevin Patrick MoranSVP CFO Treasurer2026-03-0242,442$8.27
$350.83kSell
Mihael Hristos PolymeropoulosPresident and CEO2026-03-02156,235$8.17
$1.28MSell
Joakim WijkstromSVP Chief Marketing Officer2026-03-0230,800$8.27
$254.59kSell
Timothy WilliamsSVP General Counsel2026-03-0242,434$8.27
$350.76kSell
Tage HonoreDirector2026-02-2330,000$8.03
$240.90kSell
Mihael Hristos PolymeropoulosPresident and CEO2025-08-0710,000$4.15
$41.50kBuy
Stephen Ray MitchellDirector2025-06-137,000$4.59
$32.13kSell
Mihael Hristos PolymeropoulosPresident and CEO2025-05-219,519$4.40
$41.88kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-05-21481$4.39
$2.11kBuy

1 of 2

VNDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VNDA insiders and whales buy or sell their stock.

VNDA Shareholders

What type of owners hold Vanda Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn14.67%8,669,076$60.68MInsider
Blackrock Inc13.15%7,773,535$54.41MInstitution
Vanguard Group Inc6.31%3,731,851$26.12MInstitution
Renaissance Technologies LLC5.72%3,380,961$23.67MInstitution
Kevin C. Tang4.59%2,715,852$19.01MInsider
Mihael Hristos Polymeropoulos4.58%2,704,496$18.93MInsider
Rho Ventures IV LP4.26%2,518,177$17.63MInsider
Acadian Asset Management LLC4.08%2,410,414$16.87MInstitution
Dimensional Fund Advisors LP3.58%2,118,428$14.83MInstitution
Aigh Capital Management LLC3.38%1,998,431$13.99MInstitution

1 of 3

VNDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VNDA50.12%49.88%Net SellingNet Selling
IPSC14.31%23.60%Net SellingNet Selling
ENTA64.96%35.04%Net SellingNet Selling
BNTC91.68%8.32%Net Buying
EPRX26.63%0.00%
View Top Biotech Stocks

Vanda Pharmaceuticals Stock Ownership FAQ

Who owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals (NASDAQ: VNDA) is owned by 70.87% institutional shareholders, 70.54% Vanda Pharmaceuticals insiders, and 0.00% retail investors. James E. Flynn is the largest individual Vanda Pharmaceuticals shareholder, owning 8.67M shares representing 14.67% of the company. James E. Flynn's Vanda Pharmaceuticals shares are currently valued at $60.68M.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.